Syros Pharmaceuticals is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, that works on medicines designed to control the expression of disease-causing genes. Its research centres on small molecules that target transcription factors and related pathways, with development programmes aimed at blood cancers such as myelodysplastic syndrome and acute myeloid leukaemia. The company's customers and partners are primarily the clinical investigators, hospitals and research institutions that take part in its studies of these experimental treatments.
Syros Pharmaceuticals, Inc. trades under the code 0LC7 on the London Exchange in UK, with its price quoted in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #2772 of 3787 on the London Exchange · confidence Medium
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendFair
51/100
Mixed trend against its averages.
See the numbers →
Above 200-day average42.6%
From 52-week high-50.0%
MomentumStrong
81/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return300.0%
6-month return100.0%
12-month, skipping last month0.0%
Stability (higher is calmer)Weak
1/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)772.4%
Worst drawdown, 1 year (smaller is calmer)-98.0%
LiquidityWeak
2/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.00M USD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 0.000 – 0.001Daily closes, split-adjusted
Signals
50-day average0.000
200-day average0.000
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.000
Technical summary
Daily
Neutral
7 bullish · 2 neutral · 5 bearish
Weekly
Neutral
5 bullish · 1 neutral · 6 bearish
Monthly
Bearish
2 bullish · 1 neutral · 5 bearish
Moving averages (daily)
SMA 10
0.00
Bearish
EMA 10
0.00
Bullish
SMA 20
0.00
Bearish
EMA 20
0.00
Bullish
SMA 50
0.00
Bullish
EMA 50
0.00
Bullish
SMA 100
0.00
Bullish
EMA 100
0.00
Bearish
SMA 200
0.00
Bullish
EMA 200
0.07
Bearish
Oscillators (daily)
RSI (14)
96.35
Bearish
MACD (12, 26)
0.00
Bullish
Momentum (12)
0.00
Neutral
Stochastic %K (14)
–
n/a
Williams %R (14)
–
n/a
CCI (20)
-66.67
Neutral
Pivot points (classic, last session)
S3
0.00
S2
0.00
S1
0.00
Pivot
0.00
R1
0.00
R2
0.00
R3
0.00
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.
